Clinical outcomes of eslicarbazepine acetate monotherapy for focal-onset seizures: A multicenter audit.

Beatriz G GiráldezIñigo Garamendi-RuizJorge ZuritaAlberto GarcíaRosa QuerolDulce CamposClara Cabeza-AlvarezPedro SerranoFrancisco Javier López-GonzálezAlbert MolinsJosé M Serratosa

Published in: Acta neurologica Scandinavica (2019)

Eslicarbazepine acetate was effective and well-tolerated as first-line or conversion to monotherapy in a clinical setting in adult and elderly patients with focal-onset seizures.

Keyphrases

combination therapy
open label
middle aged
temporal lobe epilepsy
double blind
young adults
childhood cancer